Although the underlying pathophysiological mechanisms are not fully understood, enhanced activation of the profibrotic transforming growth factor-β (TGF-β)/SMAD3 signaling pathway has been documented in women with AF. This evidence concerns the gene TGFB1 and atrial fibrillation.